Irene Hamrick MD, FAAFP, AGSF, CMD
Professor, Geriatrics Division; Director, Department of Family and Community Medicine; Martha Betty Semmons Endowed Chair in Geriatric Medicine; and Chief of the Office of Geriatric Medicine at the University of Cincinnati, Cincinnati, OhioDr. Irene Hamrick is a specialist in family and community medicine. After earning a bachelor’s degree in nursing at Western Carolina University, she attended East Carolina University Brody School of Medicine in Greenville, North Carolina, and completed her residency and geriatric fellowship there. She remained at Brody as faculty in the Department of Family Medicine, where she served as Director of the Geriatric Division from 2008 to 2011 and Director of the Geriatric Fellowship from 2004 to 2010. She now is Chair of the Office of Geriatrics at the University of Cincinnati, Medical Director of the Veterans Affairs (VA) Medical Center VA Nursing Home, and Inaugural Section Chief of Geriatrics, Palliative Care, and Hospice Medicine at the Cincinnati VA.
Dr. Hamrick has been recognized for educational leadership, administration, and outstanding teaching and mentoring. Her research activities include health disparities in osteoporosis, falls, dementia, computer simulation for home safety, diabetes, and dehydration.
Recent Contributions to PracticeUpdate:
- Association of Internet Usage With the Prospective Risk of Dementia
- Association of Mandatory Cognitive Testing for License Renewal With Motor Vehicle Collisions and Road Injuries
- Edema and Obstructive Sleep Apnea
- Association of Social Isolation With Dementia Risk in Community-Dwelling Medicare Beneficiaries in the US
- Effect of Cholinesterase Inhibitors on Mortality in Patients With Dementia
- Association of the Use of Hearing Aids and Cochlear Implants With Cognitive Decline and Dementia
- 2022 Top Story in Primary Care: Dementia Prevention
- From the American Geriatrics Society Annual Meeting, AGS22: AGS Beers Criteria Potentially Inappropriate Medication Use in Older Adults
- Transitioning From Insulin Therapy to DPP-4 Inhibitors in Patients With Type 2 diabetes
- Effect of Antihypertensive Classes on Cerebral Small Vessel Disease